These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 25468710

  • 1. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.
    Abdel-Fatah TM, Middleton FK, Arora A, Agarwal D, Chen T, Moseley PM, Perry C, Doherty R, Chan S, Green AR, Rakha E, Ball G, Ellis IO, Curtin NJ, Madhusudan S.
    Mol Oncol; 2015 Mar; 9(3):569-85. PubMed ID: 25468710
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers.
    Savva C, De Souza K, Ali R, Rakha EA, Green AR, Madhusudan S.
    Breast Cancer Res Treat; 2019 May; 175(1):105-115. PubMed ID: 30746633
    [Abstract] [Full Text] [Related]

  • 3. Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy.
    Al-Subhi N, Ali R, Abdel-Fatah T, Moseley PM, Chan SYT, Green AR, Ellis IO, Rakha EA, Madhusudan S.
    Breast Cancer Res Treat; 2018 Jun; 169(2):277-286. PubMed ID: 29396668
    [Abstract] [Full Text] [Related]

  • 4. Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.
    Sankunny M, Parikh RA, Lewis DW, Gooding WE, Saunders WS, Gollin SM.
    Genes Chromosomes Cancer; 2014 Feb; 53(2):129-43. PubMed ID: 24327542
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer.
    Lin WY, Brock IW, Connley D, Cramp H, Tucker R, Slate J, Reed MW, Balasubramanian SP, Cannon-Albright LA, Camp NJ, Cox A.
    PLoS One; 2013 Feb; 8(7):e68578. PubMed ID: 23844225
    [Abstract] [Full Text] [Related]

  • 8. Upregulation of the ATR-CHEK1 pathway in oral squamous cell carcinomas.
    Parikh RA, Appleman LJ, Bauman JE, Sankunny M, Lewis DW, Vlad A, Gollin SM.
    Genes Chromosomes Cancer; 2014 Jan; 53(1):25-37. PubMed ID: 24142626
    [Abstract] [Full Text] [Related]

  • 9. RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells.
    Yang X, Pan Y, Qiu Z, Du Z, Zhang Y, Fa P, Gorityala S, Ma S, Li S, Chen C, Wang H, Xu Y, Yan C, Ruth K, Ma Z, Zhang J.
    Clin Cancer Res; 2018 Apr 01; 24(7):1629-1643. PubMed ID: 29326282
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.
    Abdel-Fatah TM, Arora A, Alsubhi N, Agarwal D, Moseley PM, Perry C, Doherty R, Chan SY, Green AR, Rakha E, Ball G, Ellis IO, Madhusudan S.
    Neoplasia; 2014 Nov 01; 16(11):982-91. PubMed ID: 25425972
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.
    Sinha S, Singh RK, Bhattacharya N, Mukherjee N, Ghosh S, Alam N, Roy A, Roychoudhury S, Panda CK.
    Mol Oncol; 2011 Oct 01; 5(5):454-64. PubMed ID: 21803008
    [Abstract] [Full Text] [Related]

  • 16. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.
    Int J Mol Med; 2007 Oct 01; 20(4):605-11. PubMed ID: 17786294
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
    Arora A, Abdel-Fatah TM, Agarwal D, Doherty R, Croteau DL, Moseley PM, Hameed K, Green A, Aleskandarany MA, Rakha EA, Patterson K, Ball G, Chan SY, Ellis IO, Bohr VA, Bryant HE, Madhusudan S.
    Carcinogenesis; 2016 Jan 01; 37(1):63-71. PubMed ID: 26586793
    [Abstract] [Full Text] [Related]

  • 18. Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells.
    Gali-Muhtasib H, Kuester D, Mawrin C, Bajbouj K, Diestel A, Ocker M, Habold C, Foltzer-Jourdainne C, Schoenfeld P, Peters B, Diab-Assaf M, Pommrich U, Itani W, Lippert H, Roessner A, Schneider-Stock R.
    Cancer Res; 2008 Jul 15; 68(14):5609-18. PubMed ID: 18632613
    [Abstract] [Full Text] [Related]

  • 19. Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers.
    Lewis KA, Bakkum-Gamez J, Loewen R, French AJ, Thibodeau SN, Cliby WA.
    Genes Chromosomes Cancer; 2007 Dec 15; 46(12):1061-8. PubMed ID: 17879369
    [Abstract] [Full Text] [Related]

  • 20. The Atr-Chek1 pathway inhibits axon regeneration in response to Piezo-dependent mechanosensation.
    Li F, Lo TY, Miles L, Wang Q, Noristani HN, Li D, Niu J, Trombley S, Goldshteyn JI, Wang C, Wang S, Qiu J, Pogoda K, Mandal K, Brewster M, Rompolas P, He Y, Janmey PA, Thomas GM, Li S, Song Y.
    Nat Commun; 2021 Jun 22; 12(1):3845. PubMed ID: 34158506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.